The past several years has brought healthcare organizations closer and closer to integrating precision medicine and genomics into the daily business of care delivery. As an industry, we are nearly at the tipping point and I anticipate we will see significant acceleration towards this objective in 2019. Organizations will determine their precision medicine strategy, as well begin to develop operational processes defining how genomic data is managed and appropriately used.
